Division of Transplantation, Department of Surgery, University of Illinois at Chicago, 840 S Wood St, Suite #402 (M/C958, Chicago, IL 60612, USA.
J Hepatobiliary Pancreat Sci. 2010 Mar;17(2):97-100. doi: 10.1007/s00534-009-0146-y. Epub 2009 Oct 6.
Pancreas transplantation is a widely accepted procedure that can efficiently restore euglycemia and prevent progression of complications. In most instances, the limiting factor for deceased donor organ transplantation is the availability and quality of the available organs. Living donor pancreas transplant was introduced at the University of Minnesota in 1979. Because of the potential risks for the donor and the technical challenges in the recipient operation, this procedure has not become very popular since then. In 1999, in the attempt to decrease the morbidity associated with open distal pancreatectomy, the first laparoscopic donor distal pancreatectomy with hand-assisted technique was performed at the same institution. In 2000, the FDA approved the robotic surgical system Da Vinci for general use. Since then, the system has been extensively used at our institution to perform living donor nephrectomy. The only case reported worldwide of robotic distal pancreatectomy and nephrectomy for living donor pancreas-kidney transplantation was successfully performed by our team in 2006 at the University of Illinois at Chicago and proved as a promising technique. The application of minimally invasive techniques has allowed an increased acceptance of the procedure among potential donors and may, therefore, increase the number of donors for this life-saving transplant. The initial results are encouraging and clearly prove feasibility.
胰腺移植是一种广泛接受的手术,可以有效地恢复正常血糖水平,并预防并发症的进展。在大多数情况下,限制已故供体器官移植的因素是可用器官的数量和质量。活体供体胰腺移植于 1979 年在明尼苏达大学引入。由于供体存在潜在风险,以及受体手术中的技术挑战,此后该手术并未得到广泛应用。1999 年,为了降低开放性胰体尾切除术相关的发病率,同一家机构首次进行了腹腔镜辅助的手助式活体供体胰体尾切除术。2000 年,FDA 批准达芬奇机器人手术系统用于普通外科。从那时起,该系统已在我们机构广泛用于活体供肾切除术。2006 年,我们团队在伊利诺伊大学芝加哥分校成功完成了世界上首例机器人辅助活体供体胰腺-肾脏移植的胰体尾切除术和肾切除术,证明了这是一种有前途的技术。微创技术的应用使潜在供体更容易接受该手术,因此可能会增加这种救命移植的供体数量。初步结果令人鼓舞,明确证明了该手术的可行性。